Recruiting Alpha-1 Antitrypsin Deficiency Studies in Colorado Springs
About Alpha-1 Antitrypsin Deficiency Clinical Trials in Colorado Springs
Alpha-1 antitrypsin deficiency is a genetic condition that increases the risk of lung and liver disease due to low levels of the protective protein alpha-1 antitrypsin. It is one of the most common genetic causes of COPD. Treatment includes augmentation therapy and management of lung and liver symptoms.
There are currently 2 alpha-1 antitrypsin deficiency clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 210 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alpha-1 Antitrypsin Deficiency Clinical Trials in Colorado Springs — FAQ
Are there alpha-1 antitrypsin deficiency clinical trials in Colorado Springs?
Yes, there are 2 alpha-1 antitrypsin deficiency clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Colorado Springs?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.
Are clinical trials in Colorado Springs free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.
What alpha-1 antitrypsin deficiency treatments are being tested?
The 2 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for alpha-1 antitrypsin deficiency.
Data updated October 15, 2026 from ClinicalTrials.gov